Search

everythinglearnresearchcommunity

for

Search:↓

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The Ovol2-Zeb1 circuit is crucial for skin healing and hair growth by guiding cell movement and growth.

Nanoencapsulation creates adjustable cell clusters for hair growth.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Wounds heal without scarring in early development but later result in scars, and studying Wnt signaling could help control scarring.

SHBG binding properties are unchanged in male liver cirrhosis patients.

New treatments for psoriasis have improved effectiveness and may reduce long-term side effects when combined with standard therapies.

The 3D scaffold helped maintain hair cell traits and could improve hair loss treatments.

The experiment showed that human skin grown in the lab started to form early hair structures when special cell clusters were added.

Fat stem cells from diabetic mice can help heal skin wounds in other diabetic mice.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Meis1 is crucial for skin health and tumor development.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Rats had lasting erectile problems after stopping a certain medication.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

New skin substitutes for treating severe burns and chronic wounds are being developed, but a permanent solution for deep wounds is not yet available commercially.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.

Certain human skin cells marked by CD44 and ALDH are rich in stem cells capable of long-term skin renewal.

Early hair loss may indicate prostate issues.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Low iron levels are linked to more hair loss in non-menopausal women.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

The study concluded that three enzymes are important for plant development by affecting sugar composition and calcium binding in plants.